A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

Boryung

Status: Enrolling

Conditions: Mixed Dyslipidemia; Primary Hypercholesterolemia

Study type: Observational

Funder types: Industry

Identifiers

NCT06314919

BR-PEC-OS-401

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition

Enrollment: 8,606 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Those who taking statins or statins and ezetimibe in addition to dietary and exercise therapy for primary hypercholesterolemia or mixed hyperlipidemia
• Those who are judged to need administration of a fixed-dose combination of pitavastatin/ezetimibe for change of statin's formulation or change of statin's dose, addition of ezetimibe

Exclusion criteria

• Those who are taking a fixed-dose combination of pitavastatin/ezetimibe at study enrollment
• Those with hypersensitivity reactions or relevant medical history to pitavastatin or ezetimibe
• Those who have been administered an investigational product within 12 weeks of the enrollment date or are planning to participate in another clinical trial during this study participation period.